Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
3,1 USD | +3,68% | -4,02% | -3,73% |
Métier
Nombre d'employés: 40
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -73,93% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -73,93% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 01/04/14 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 01/01/19 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 28/06/23 |
Manoj Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 08/02/23 |
Jason Tardio
COO | Chief Operating Officer | 47 | 18/11/19 |
Julia Tsai
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/21 |
Thomas Perone
CMP | Compliance Officer | 59 | 21/03/19 |
Toshiya Nishi
PRN | Corporate Officer/Principal | - | 08/02/23 |
Megan Alexander
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01/09/15 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 14/06/17 |
Bart Friedman
BRD | Director/Board Member | 79 | 23/11/15 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 01/04/14 |
Karen Bernstein
BRD | Director/Board Member | 71 | 30/09/15 |
Robert Poole
BRD | Director/Board Member | 67 | 09/07/21 |
Kevin Fitzgerald
BRD | Director/Board Member | 56 | 06/10/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 70 810 661 | 59 503 870 ( 84,03 %) | 0 | 84,03 % |
Action B | 0 | 1 250 | 0 | 0 |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-3,73% | 220 M | |
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,73 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |
- Bourse
- Actions
- Action OVID
- Société Ovid Therapeutics Inc.